National Academies Press: OpenBook
« Previous: Appendix C: Statement of Task
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×

D
Registered Attendees

Nicholas Allen

PXE International

Margaret Anderson

FasterCures

Ronald Anson

American College of Cardiology

Daniel Arias

Enetic Alliance

Krishna Balakrishnan

National Center for Advancing Translational Sciences

Jeannie Baumann

Bloomberg BNA

Paul Billings

Life Technologies Corporation

Julie Bolliner

Johns Hopkins University

Khaled Bouri

U.S. Food and Drug Administration

Henry Brem

Johns Hopkins University School of Medicine

Ethan Brenna

Genetic Alliance

Joel Brill

Predictive Health, LLC

Eric Caplan

Biopractices, LLC

Daniel Carlat

Pew Charitable Trusts

Ann Cashion

National Institute of Nursing Research

Guy Chisolm

Cleveland Clinic

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×

Neal Cohen

University of California, San Francisco

Anthony Coyle

Pfizer Inc.

Alyna Dada

Genetic Alliance

Rebecca English

Institute of Medicine

Raith Erickson

Complete Genomics

Stephanie Fischer

PhRMA

J. Michael Fitzmaurice

Agency for Healthcare Research and Quality

Scott Fogerty

Covance

Daria Grayer

Association of American Medical Colleges

Mary Grealy

Healthcare Leadership Council

Rachel Hickey

Genetic Alliance

Jennifer Hobin

American Association for Cancer Research

Kathi Huddleston

Inova Translational Medicine Institute

David Innes

Mercer University

Rasika Kalamegham

American Association for Cancer Research

Francis Kalush

U.S. Food and Drug Administration

Steven Krosnick

National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health

Katherine Lambertson

Genetic Alliance

Gabriela Lavezzari

PhRMA

Mark Lee

U.S. Food and Drug Administration

Allen Lichter

American Society of Clinical Oncology

Bernard Lo

Greenwall Foundation

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×

Savickis Mari

American Medical Association

James Matthews

Sanofi Pasteur

Michelle McMurry-Heath

U.S. Food and Drug Administration

Kelly McVearry

Northrop Grumman

Anne Michaels

MNA, Inc.

Joseph Morgan

Cleveland Clinic

Neal Neuberger

Health Tech Strategies

Steve Olson

Institute of Medicine Consultant

Charles Ornstein

ProPublica

Heather Pierce

Association of American Medical Colleges

Ronald Przygodzki

U.S. Department of Veterans Affairs

Sally Rockey

National Institutes of Health

Allen Roses

Duke University

Deborah Runkle

American Association for the Advancement of Science

Kalyn Saulsberry

Genetic Alliance

Michele Schoonmaker

Cepheid

Sal Shah

Shah Associates, LLC

Shruti Sharma

Genetic Alliance

Todd Sherer

Emory University

Ira Shoulson

Georgetown University

Moushumi Sinha

Genetic Alliance

Mark Sobel

American Society for Investigative Pathology

Rebecca Spence

American Society of Clinical Oncology

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×

Scott Steele

University of Rochester

Catherine Stevenson

Genetic Alliance

Sharon Terry

Genetic Alliance

Jill Hartzler Warner

U.S. Food and Drug Administration

Jennifer Weisman

Strategic Analysis, Inc.

Angele White

Fair Chance, Inc.

David Wierz

OCI, LLC

Erin Wilhelm

Georgetown University

Crispin Woolston

Sanofi

Rachel Zetts

Pew Charitable Trusts

Dorit Zuk

National Institutes of Health

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 75
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 76
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 77
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 78
Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary Get This Book
×
Buy Paperback | $39.00 Buy Ebook | $31.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Scientific advances such as the sequencing of the human genome have created great promise for improving human health by providing a greater understanding of disease biology and enabling the development of new drugs, diagnostics, and preventive services. However, the translation of research advances into clinical applications has so far been slower than anticipated. This is due in part to the complexity of the underlying biology as well as the cost and time it takes to develop a product. Pharmaceutical companies are adapting their business models to this new reality for product development by placing increasing emphasis on leveraging alliances, joint development efforts, early-phase research partnerships, and public-private partnerships. These collaborative efforts make it possible to identify new drug targets, enhance the understanding of the underlying basis of disease, discover novel indications for the use of already approved products, and develop biomarkers for disease outcomes or directed drug use. While the potential benefits of collaboration are significant, the fact that the relationships among development partners are often financial means that it is vital to ensure trust by identifying, disclosing, and managing any potential sources of conflict that could create bias in the research being performed together.

Conflict of Interest and Medical Innovation is the summary of a workshop convened by the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health in June 2013 to explore the appropriate balance between identifying and managing conflicts of interest and advancing medical innovation. A wide range of stakeholders, including government officials, pharmaceutical company representatives, academic administrators and researchers, health care providers, medical ethicists, patient advocates, and consumers, were invited to present their perspectives and participate in discussions during the workshop. This report focuses on current conflict of interest policies and their effect on medical innovation in an effort to identify best practices and potential solutions for facilitating innovation while still ensuring scientific integrity and public trust.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!